Share Price and Basic Stock Data
Last Updated: December 11, 2025, 3:25 am
| PEG Ratio | 0.53 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Eureka Forbes Ltd, a prominent player in the domestic appliances sector, has shown a remarkable recovery in revenue over recent years. The company reported sales of ₹2,080 Cr for FY 2023, a significant leap from just ₹381 Cr in FY 2022. This upward trajectory continued with a trailing twelve months (TTM) revenue of ₹2,491 Cr. The quarterly sales figures also reflect this growth, with the latest quarter ending September 2024 recording ₹673 Cr, up from ₹505 Cr in the previous quarter. Such consistent revenue growth highlights a robust demand for Eureka Forbes’ products, which include water purifiers and vacuum cleaners, amidst increasing consumer awareness regarding health and hygiene. However, it’s important to note that while the sales figures are impressive, the company’s historical context shows fluctuations, particularly during the pandemic years when revenues dipped significantly. This raises questions about the sustainability of the current growth trend.
Profitability and Efficiency Metrics
Despite the impressive revenue figures, Eureka Forbes has faced challenges in profitability. The company reported a net profit of ₹171 Cr for FY 2025, translating to a net profit margin of 6.74%, which, while improved, remains modest in comparison to industry peers. The operating profit margin (OPM) stood at 11.49% for the same period, indicating a gradual improvement from previous years. However, the return on equity (ROE) at 3.69% and return on capital employed (ROCE) at 5.04% are relatively low, suggesting that while revenue is growing, the efficiency in generating profits from that revenue is not as strong as one might hope. The interest coverage ratio, a healthy 49.77x, indicates that the company can comfortably meet its interest obligations, which is a reassuring sign for investors. Still, the efficiency metrics suggest that there’s room for improvement in translating sales into substantial profits.
Balance Sheet Strength and Financial Ratios
Eureka Forbes boasts a solid balance sheet, with total borrowings reported at a mere ₹26 Cr, indicating a very low level of debt relative to its equity. This positions the company well in terms of financial stability. The reserves have steadily increased, reaching ₹4,191 Cr in FY 2025, which not only provides a cushion against unforeseen challenges but also reflects retained earnings for future growth. The current ratio of 0.83 suggests that the company may have some liquidity concerns, as it is below the ideal threshold of 1. However, the quick ratio of 0.57 indicates that immediate liquidity is even tighter. Furthermore, with a price-to-book value (P/BV) ratio of 2.38x, investors are paying a premium for the stock relative to its book value, which could indicate strong market confidence or potentially overvaluation if growth does not continue.
Shareholding Pattern and Investor Confidence
The shareholding structure of Eureka Forbes reveals a significant concentration of ownership, with promoters holding 62.56% of the shares. This level of control can be both a strength and a risk; it may provide stability in decision-making but also raises concerns about minority shareholder influence. The foreign institutional investors (FIIs) have increased their stake to 13.72%, while domestic institutional investors (DIIs) hold 6.38%. The rise in public shareholding from 12.90% in December 2022 to 16.48% in March 2025 reflects growing investor interest, possibly due to the company’s strong recovery trajectory. The number of shareholders has also increased significantly, which is a positive sign of increasing retail interest. However, the heavy promoter holding could lead to governance issues if future decisions do not align with the interests of minority shareholders.
Outlook, Risks, and Final Insight
The outlook for Eureka Forbes appears cautiously optimistic, driven by rising sales and improved profitability metrics. However, the company must address its efficiency ratios to enhance shareholder value more effectively. One significant risk is the potential for market saturation in the domestic appliances sector, which could hinder future growth. Additionally, any economic downturn or shifts in consumer spending could adversely impact sales. Investors should remain vigilant about these risks while also considering the company’s low debt levels and improving profit margins as strengths. The balance between leveraging growth opportunities and managing operational efficiencies will be critical for Eureka Forbes as it navigates the competitive landscape. Overall, while there are promising signs, the journey towards sustainable growth and profitability remains complex and requires careful observation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Eureka Forbes Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| MPL Plastics Ltd | 10.8 Cr. | 8.68 | 14.2/7.61 | 3.04 | 0.00 % | 4,800 % | % | 10.0 | |
| Hawkins Cookers Ltd | 4,333 Cr. | 8,191 | 9,900/7,100 | 38.2 | 704 | 1.59 % | 40.9 % | 32.0 % | 10.0 |
| Harsha Engineers International Ltd | 3,315 Cr. | 364 | 546/330 | 25.2 | 147 | 0.27 % | 13.5 % | 6.11 % | 10.0 |
| Gorani Industries Ltd | 35.4 Cr. | 66.1 | 126/60.5 | 30.3 | 25.5 | 0.00 % | 9.70 % | 6.68 % | 10.0 |
| Eureka Forbes Ltd | 12,523 Cr. | 648 | 668/452 | 68.0 | 232 | 0.00 % | 5.04 % | 3.69 % | 10.0 |
| Industry Average | 9,203.67 Cr | 1,427.34 | 51.91 | 210.98 | 0.44% | 357.66% | 11.88% | 6.57 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 525 | 575 | 472 | 508 | 505 | 592 | 539 | 553 | 553 | 673 | 598 | 613 | 608 |
| Expenses | 482 | 575 | 431 | 461 | 459 | 541 | 496 | 500 | 498 | 601 | 539 | 535 | 546 |
| Operating Profit | 43 | 0 | 41 | 47 | 46 | 51 | 42 | 53 | 55 | 72 | 59 | 78 | 61 |
| OPM % | 8% | 0% | 9% | 9% | 9% | 9% | 8% | 10% | 10% | 11% | 10% | 13% | 10% |
| Other Income | 1 | -15 | -10 | -5 | 2 | 2 | 3 | -13 | 2 | 6 | 4 | 6 | 7 |
| Interest | 6 | 6 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Depreciation | 13 | 16 | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 | 15 | 15 | 16 |
| Profit before tax | 24 | -36 | 13 | 26 | 31 | 37 | 30 | 24 | 42 | 62 | 47 | 68 | 52 |
| Tax % | 27% | -26% | 25% | 37% | 29% | 31% | 25% | 12% | 25% | 25% | 26% | 25% | 25% |
| Net Profit | 18 | -27 | 10 | 16 | 22 | 25 | 23 | 21 | 31 | 47 | 35 | 51 | 39 |
| EPS in Rs | 0.92 | -1.39 | 0.51 | 0.84 | 1.14 | 1.32 | 1.17 | 1.11 | 1.61 | 2.41 | 1.80 | 2.62 | 1.99 |
Last Updated: August 19, 2025, 3:46 pm
Below is a detailed analysis of the quarterly data for Eureka Forbes Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 608.00 Cr.. The value appears to be declining and may need further review. It has decreased from 613.00 Cr. (Mar 2025) to 608.00 Cr., marking a decrease of 5.00 Cr..
- For Expenses, as of Jun 2025, the value is 546.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 535.00 Cr. (Mar 2025) to 546.00 Cr., marking an increase of 11.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 78.00 Cr. (Mar 2025) to 61.00 Cr., marking a decrease of 17.00 Cr..
- For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 13.00% (Mar 2025) to 10.00%, marking a decrease of 3.00%.
- For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Mar 2025) to 16.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 52.00 Cr., marking a decrease of 16.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
- For Net Profit, as of Jun 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Mar 2025) to 39.00 Cr., marking a decrease of 12.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.99. The value appears to be declining and may need further review. It has decreased from 2.62 (Mar 2025) to 1.99, marking a decrease of 0.63.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:23 am
| Metric | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 28 | 33 | 27 | 26 | 16 | 8 | 381 | 2,080 | 2,189 | 2,436 | 2,491 |
| Expenses | 0 | 0 | 28 | 32 | 27 | 26 | 16 | 9 | 363 | 1,949 | 1,997 | 2,173 | 2,222 |
| Operating Profit | 0 | 0 | 1 | 2 | -1 | -0 | -0 | -1 | 18 | 132 | 192 | 263 | 269 |
| OPM % | 2% | 5% | -3% | -1% | -0% | -17% | 5% | 6% | 9% | 11% | 11% | ||
| Other Income | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 2 | -30 | -7 | 19 | 24 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 4 | 20 | 10 | 6 | 5 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 55 | 53 | 58 | 60 |
| Profit before tax | 0 | 0 | 0 | 1 | -1 | -1 | -1 | -2 | 7 | 27 | 122 | 219 | 229 |
| Tax % | -8% | 8% | 9% | -9% | 56% | 1% | 59% | 37% | 25% | 25% | |||
| Net Profit | 0 | 0 | 0 | 1 | -1 | -1 | -1 | -2 | 3 | 17 | 92 | 163 | 171 |
| EPS in Rs | 0.00 | 0.00 | 0.50 | 2.62 | -4.70 | -2.48 | -1.84 | -3.38 | 0.14 | 0.88 | 4.73 | 8.44 | 8.82 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -200.00% | 0.00% | 0.00% | -100.00% | 250.00% | 466.67% | 441.18% | 77.17% |
| Change in YoY Net Profit Growth (%) | 0.00% | 200.00% | 0.00% | -100.00% | 350.00% | 216.67% | -25.49% | -364.00% |
Eureka Forbes Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 172% |
| 3 Years: | 86% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 183% |
| 3 Years: | 294% |
| TTM: | 50% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 7% |
| 1 Year: | 20% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 3:26 pm
Balance Sheet
Last Updated: December 10, 2025, 4:16 am
| Month | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 0.05 | 3 | 3 | 3 | 3 | 5 | 5 | 193 | 193 | 193 | 193 | 193 |
| Reserves | -0 | -0 | -1 | -0 | -2 | -2 | -3 | -5 | 3,874 | 3,886 | 4,010 | 4,191 | 4,302 |
| Borrowings | 0 | 0 | 4 | 4 | 4 | 4 | 2 | 2 | 253 | 139 | 39 | 26 | 91 |
| Other Liabilities | 0 | 0 | 12 | 12 | 9 | 9 | 7 | 5 | 1,815 | 1,810 | 1,878 | 1,899 | 2,176 |
| Total Liabilities | 0 | 0 | 18 | 18 | 14 | 14 | 10 | 7 | 6,135 | 6,029 | 6,120 | 6,310 | 6,762 |
| Fixed Assets | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5,498 | 5,475 | 5,457 | 5,466 | 5,486 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87 | 101 | 80 | 84 | 86 |
| Other Assets | 0 | 0 | 17 | 18 | 14 | 14 | 10 | 7 | 550 | 451 | 582 | 758 | 1,185 |
| Total Assets | 0 | 0 | 18 | 18 | 14 | 14 | 10 | 7 | 6,135 | 6,029 | 6,120 | 6,310 | 6,762 |
Below is a detailed analysis of the balance sheet data for Eureka Forbes Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 193.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 193.00 Cr..
- For Reserves, as of Sep 2025, the value is 4,302.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,191.00 Cr. (Mar 2025) to 4,302.00 Cr., marking an increase of 111.00 Cr..
- For Borrowings, as of Sep 2025, the value is 91.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 26.00 Cr. (Mar 2025) to 91.00 Cr., marking an increase of 65.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2,176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,899.00 Cr. (Mar 2025) to 2,176.00 Cr., marking an increase of 277.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 6,762.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,310.00 Cr. (Mar 2025) to 6,762.00 Cr., marking an increase of 452.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5,486.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,466.00 Cr. (Mar 2025) to 5,486.00 Cr., marking an increase of 20.00 Cr..
- For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 86.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Mar 2025) to 86.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,185.00 Cr.. The value appears strong and on an upward trend. It has increased from 758.00 Cr. (Mar 2025) to 1,185.00 Cr., marking an increase of 427.00 Cr..
- For Total Assets, as of Sep 2025, the value is 6,762.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,310.00 Cr. (Mar 2025) to 6,762.00 Cr., marking an increase of 452.00 Cr..
Notably, the Reserves (4,302.00 Cr.) exceed the Borrowings (91.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | 0.00 | -3.00 | -2.00 | -5.00 | -4.00 | -2.00 | -3.00 | -235.00 | -7.00 | 153.00 | 237.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 156 | 141 | 107 | 110 | 63 | 110 | 147 | 22 | 23 | 27 | ||
| Inventory Days | 34 | 21 | 37 | 33 | 90 | 109 | 638 | 91 | 99 | 87 | ||
| Days Payable | 164 | 153 | 137 | 143 | 159 | 256 | 549 | 99 | 89 | 67 | ||
| Cash Conversion Cycle | 26 | 10 | 7 | 1 | -7 | -37 | 235 | 14 | 33 | 47 | ||
| Working Capital Days | 37 | 34 | 31 | -48 | -33 | -105 | -546 | -103 | -87 | -71 | ||
| ROCE % | 0% | 20% | 24% | -12% | -5% | -4% | -58% | 0% | 2% | 3% | 5% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Small Cap Fund | 1,121,339 | 0.53 | 62.62 | 1,121,339 | 2025-04-22 17:25:12 | 0% |
| Aditya Birla Sun Life Consumption Fund | 1,062,523 | 0.91 | 59.33 | N/A | N/A | N/A |
| ICICI Prudential Bharat Consumption Fund | 976,728 | 1.67 | 54.54 | N/A | N/A | N/A |
| Union Small Cap Fund | 871,647 | 2.72 | 48.67 | 372,980 | 2025-11-02 05:15:23 | 133.7% |
| Aditya Birla Sun Life MNC Fund | 625,311 | 0.93 | 34.92 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 565,642 | 0.18 | 31.59 | 693,139 | 2025-11-03 14:33:44 | -18.39% |
| WhiteOak Capital Flexi Cap Fund | 559,687 | 0.48 | 31.25 | N/A | N/A | N/A |
| PGIM India Small Cap Fund | 448,735 | 1.53 | 25.06 | 527,250 | 2025-11-02 05:15:23 | -14.89% |
| LIC MF ELSS Tax Saver Fund | 285,361 | 1.43 | 15.93 | N/A | N/A | N/A |
| WhiteOak Capital Mid Cap Fund | 244,189 | 0.33 | 13.64 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.46 | 4.94 | 1.37 | 0.72 | -3.38 |
| Diluted EPS (Rs.) | 8.46 | 4.93 | 1.37 | 0.72 | -3.38 |
| Cash EPS (Rs.) | 11.49 | 7.74 | 4.29 | 0.60 | -3.08 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 227.86 | 218.47 | 211.85 | 210.74 | 0.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 227.86 | 218.47 | 211.85 | 210.74 | 0.28 |
| Revenue From Operations / Share (Rs.) | 125.95 | 113.15 | 107.74 | 19.73 | 16.25 |
| PBDIT / Share (Rs.) | 14.48 | 10.72 | 8.02 | 1.07 | -2.65 |
| PBIT / Share (Rs.) | 11.48 | 7.93 | 5.11 | 0.59 | -2.95 |
| PBT / Share (Rs.) | 11.41 | 6.64 | 1.99 | 0.36 | -3.36 |
| Net Profit / Share (Rs.) | 8.50 | 4.94 | 1.37 | 0.13 | -3.38 |
| NP After MI And SOA / Share (Rs.) | 8.50 | 4.94 | 1.37 | 0.13 | -3.38 |
| PBDIT Margin (%) | 11.49 | 9.47 | 7.44 | 5.41 | -16.34 |
| PBIT Margin (%) | 9.11 | 7.00 | 4.73 | 3.00 | -18.14 |
| PBT Margin (%) | 9.05 | 5.86 | 1.84 | 1.84 | -20.67 |
| Net Profit Margin (%) | 6.74 | 4.36 | 1.26 | 0.68 | -20.77 |
| NP After MI And SOA Margin (%) | 6.74 | 4.36 | 1.27 | 0.68 | -20.77 |
| Return on Networth / Equity (%) | 3.72 | 2.26 | 0.64 | 0.06 | -1175.41 |
| Return on Capital Employeed (%) | 4.12 | 2.96 | 1.94 | 0.22 | -886.48 |
| Return On Assets (%) | 2.59 | 1.56 | 0.44 | 0.04 | -22.82 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.05 | 10.81 |
| Asset Turnover Ratio (%) | 0.39 | 0.36 | 0.34 | 0.12 | 0.00 |
| Current Ratio (X) | 0.83 | 0.63 | 0.52 | 0.54 | 0.75 |
| Quick Ratio (X) | 0.57 | 0.37 | 0.28 | 0.26 | 0.46 |
| Inventory Turnover Ratio (X) | 9.64 | 3.47 | 2.57 | 0.73 | 0.00 |
| Interest Coverage Ratio (X) | 49.77 | 21.22 | 7.66 | 4.67 | -6.45 |
| Interest Coverage Ratio (Post Tax) (X) | 29.47 | 12.34 | 4.28 | 1.59 | -7.20 |
| Enterprise Value (Cr.) | 10241.93 | 8769.60 | 8356.88 | 7796.16 | 0.00 |
| EV / Net Operating Revenue (X) | 4.20 | 4.01 | 4.01 | 20.42 | 0.00 |
| EV / EBITDA (X) | 36.56 | 42.28 | 53.83 | 377.28 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 4.31 | 4.04 | 3.96 | 19.83 | 0.00 |
| Price / BV (X) | 2.38 | 2.09 | 2.01 | 1.86 | 0.00 |
| Price / Net Operating Revenue (X) | 4.31 | 4.04 | 3.96 | 19.83 | 0.00 |
| EarningsYield | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for Eureka Forbes Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.46. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 8.46, marking an increase of 3.52.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.46. This value is within the healthy range. It has increased from 4.93 (Mar 24) to 8.46, marking an increase of 3.53.
- For Cash EPS (Rs.), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 7.74 (Mar 24) to 11.49, marking an increase of 3.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.86. It has increased from 218.47 (Mar 24) to 227.86, marking an increase of 9.39.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 227.86. It has increased from 218.47 (Mar 24) to 227.86, marking an increase of 9.39.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 125.95. It has increased from 113.15 (Mar 24) to 125.95, marking an increase of 12.80.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 14.48. This value is within the healthy range. It has increased from 10.72 (Mar 24) to 14.48, marking an increase of 3.76.
- For PBIT / Share (Rs.), as of Mar 25, the value is 11.48. This value is within the healthy range. It has increased from 7.93 (Mar 24) to 11.48, marking an increase of 3.55.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 6.64 (Mar 24) to 11.41, marking an increase of 4.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 8.50, marking an increase of 3.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.50. This value is within the healthy range. It has increased from 4.94 (Mar 24) to 8.50, marking an increase of 3.56.
- For PBDIT Margin (%), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 9.47 (Mar 24) to 11.49, marking an increase of 2.02.
- For PBIT Margin (%), as of Mar 25, the value is 9.11. This value is below the healthy minimum of 10. It has increased from 7.00 (Mar 24) to 9.11, marking an increase of 2.11.
- For PBT Margin (%), as of Mar 25, the value is 9.05. This value is below the healthy minimum of 10. It has increased from 5.86 (Mar 24) to 9.05, marking an increase of 3.19.
- For Net Profit Margin (%), as of Mar 25, the value is 6.74. This value is within the healthy range. It has increased from 4.36 (Mar 24) to 6.74, marking an increase of 2.38.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.74. This value is below the healthy minimum of 8. It has increased from 4.36 (Mar 24) to 6.74, marking an increase of 2.38.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.72. This value is below the healthy minimum of 15. It has increased from 2.26 (Mar 24) to 3.72, marking an increase of 1.46.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.12. This value is below the healthy minimum of 10. It has increased from 2.96 (Mar 24) to 4.12, marking an increase of 1.16.
- For Return On Assets (%), as of Mar 25, the value is 2.59. This value is below the healthy minimum of 5. It has increased from 1.56 (Mar 24) to 2.59, marking an increase of 1.03.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.39. It has increased from 0.36 (Mar 24) to 0.39, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1.5. It has increased from 0.63 (Mar 24) to 0.83, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.57, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.64. This value exceeds the healthy maximum of 8. It has increased from 3.47 (Mar 24) to 9.64, marking an increase of 6.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 49.77. This value is within the healthy range. It has increased from 21.22 (Mar 24) to 49.77, marking an increase of 28.55.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 29.47. This value is within the healthy range. It has increased from 12.34 (Mar 24) to 29.47, marking an increase of 17.13.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,241.93. It has increased from 8,769.60 (Mar 24) to 10,241.93, marking an increase of 1,472.33.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.20. This value exceeds the healthy maximum of 3. It has increased from 4.01 (Mar 24) to 4.20, marking an increase of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 36.56. This value exceeds the healthy maximum of 15. It has decreased from 42.28 (Mar 24) to 36.56, marking a decrease of 5.72.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has increased from 4.04 (Mar 24) to 4.31, marking an increase of 0.27.
- For Price / BV (X), as of Mar 25, the value is 2.38. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 2.38, marking an increase of 0.29.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has increased from 4.04 (Mar 24) to 4.31, marking an increase of 0.27.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Eureka Forbes Ltd:
- Net Profit Margin: 6.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.12% (Industry Average ROCE: 357.66%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.72% (Industry Average ROE: 11.88%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 29.47
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 68 (Industry average Stock P/E: 51.91)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Domestic Appliances | B1/B2, 7th Floor, Mumbai Maharashtra 400013 | compliance@eurekaforbes.com http://www.eurekaforbes.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arvind Uppal | Chairman, Non Ind & Non Exe Director |
| Mr. Pratik Rashmikant Pota | Managing Director & CEO |
| Mr. Shashank Shankar Samant | Independent Director |
| Mr. Sahil Dilip Dalal | Non Exe.Non Ind.Director |
| Mrs. Gurveen Singh | Independent Director |
| Mr. Vinod Rao | Independent Director |
| Mr. Homi Adi Katgara | Independent Director |
FAQ
What is the intrinsic value of Eureka Forbes Ltd?
Eureka Forbes Ltd's intrinsic value (as of 11 December 2025) is 475.02 which is 26.69% lower the current market price of 648.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12,523 Cr. market cap, FY2025-2026 high/low of 668/452, reserves of ₹4,302 Cr, and liabilities of 6,762 Cr.
What is the Market Cap of Eureka Forbes Ltd?
The Market Cap of Eureka Forbes Ltd is 12,523 Cr..
What is the current Stock Price of Eureka Forbes Ltd as on 11 December 2025?
The current stock price of Eureka Forbes Ltd as on 11 December 2025 is 648.
What is the High / Low of Eureka Forbes Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Eureka Forbes Ltd stocks is 668/452.
What is the Stock P/E of Eureka Forbes Ltd?
The Stock P/E of Eureka Forbes Ltd is 68.0.
What is the Book Value of Eureka Forbes Ltd?
The Book Value of Eureka Forbes Ltd is 232.
What is the Dividend Yield of Eureka Forbes Ltd?
The Dividend Yield of Eureka Forbes Ltd is 0.00 %.
What is the ROCE of Eureka Forbes Ltd?
The ROCE of Eureka Forbes Ltd is 5.04 %.
What is the ROE of Eureka Forbes Ltd?
The ROE of Eureka Forbes Ltd is 3.69 %.
What is the Face Value of Eureka Forbes Ltd?
The Face Value of Eureka Forbes Ltd is 10.0.